Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 Sep 22 EFFECT Notice of effectiveness
- 21 Sep 22 POS AM Prospectus update (post-effective amendment)
- 10 Aug 22 424B3 Prospectus supplement
- 10 Jun 22 424B3 Prospectus supplement
- 11 May 22 424B3 Prospectus supplement
- 1 Apr 22 EFFECT Notice of effectiveness
-
28 Mar 22 POS AM Prospectus update (post-effective amendment)
- 9 Nov 21 424B3 Prospectus supplement
- 8 Oct 21 424B3 Prospectus supplement
- 30 Sep 21 EFFECT Notice of effectiveness
- 29 Sep 21 424B3 Prospectus supplement
- 10 Sep 21 S-1 IPO registration
TNGX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of Tango Therapeutics, Inc. of our report dated March 28, 2022, relating to the financial statements of Tango Therapeutics, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 28, 2022